• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

减重手术引起的体重减轻可降低肝脂质过氧化水平,并影响肝细胞色素 P-450 蛋白含量。

Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.

机构信息

Division of Clinical Pharmacology , Indiana University, Indianapolis, IN 46202, USA.

出版信息

Ann Surg. 2010 Jun;251(6):1041-8. doi: 10.1097/SLA.0b013e3181dbb572.

DOI:10.1097/SLA.0b013e3181dbb572
PMID:20485142
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2903202/
Abstract

OBJECTIVE

To evaluate the effects of surgical weight loss on hepatic lipid peroxidation levels and cytochrome P-450 protein expression in patients with nonalcoholic fatty liver disease (NAFLD).

SUMMARY BACKGROUND DATA

NAFLD and nonalcoholic steatohepatitis (NASH) affect hepatic cytochrome P-450 (CYP) protein expression and activity, and CYP2E1 may play a role in the pathogenesis of NAFLD and NASH through induction of oxidative stress and lipid peroxidation. NAFLD and NASH are associated with increased systemic lipid peroxidation levels and elevated hepatic CYP2E1 activity, but hepatic CYP3A4/5 activity is decreased.

METHODS

Liver biopsies from 20 patients with NAFLD who underwent bariatric surgery were obtained intraoperatively and at 15 +/- 7 months following surgery. Hepatic malondialdehyde (MDA) levels (a marker of lipid peroxidation), CYP2E1 and CYP3A4/5 protein expression, and steatosis, as a percent of total area, were measured by immunohistochemistry followed by digital image quantitation.

RESULTS

Following weight loss, as reflected by reduced BMI (54 +/- 9 vs. 37 +/- 9 kg/m2; P < 0.001), features of the metabolic syndrome, grade and stage of liver disease, and liver histology were all significantly improved (P < 0.01). Hepatic MDA staining (35 +/- 18% vs. 23 +/- 14%; P = 0.02), CYP2E1 protein content (68 +/- 9% vs. 56 +/- 11%; P < 0.001), and steatosis (17 +/- 7% vs. 2 +/- 3%; P < 0.001) were significantly reduced following weight loss. CYP3A4/5 protein content was unchanged (57 +/- 13% vs. 55 +/- 13%; P = 0.433). The reduction in lipid peroxidation was independently associated with changes in CYP2E1 protein expression after bariatric surgery (r = 0.477; P = 0.033).

CONCLUSION

Elevations in hepatic lipid peroxidation and CYP2E1 expression that are seen in NAFLD improve significantly with weight loss induced by bariatric surgery.

摘要

目的

评估手术减肥对非酒精性脂肪性肝病(NAFLD)患者肝脂质过氧化水平和细胞色素 P-450 蛋白表达的影响。

背景资料概要

NAFLD 和非酒精性脂肪性肝炎(NASH)影响肝细胞色素 P-450(CYP)蛋白表达和活性,CYP2E1 可能通过诱导氧化应激和脂质过氧化在 NAFLD 和 NASH 的发病机制中发挥作用。NAFLD 和 NASH 与全身性脂质过氧化水平升高和肝 CYP2E1 活性升高有关,但肝 CYP3A4/5 活性降低。

方法

对 20 例接受减肥手术的 NAFLD 患者术中及术后 15±7 个月获得肝活检,通过免疫组织化学法和数字图像定量法检测肝丙二醛(MDA)水平(脂质过氧化的标志物)、CYP2E1 和 CYP3A4/5 蛋白表达以及作为总面积百分比的脂肪变性。

结果

体重减轻反映为 BMI 降低(54±9 与 37±9kg/m2;P<0.001),代谢综合征特征、肝脏疾病分级和分期以及肝组织学均显著改善(P<0.01)。肝 MDA 染色(35±18%与 23±14%;P=0.02)、CYP2E1 蛋白含量(68±9%与 56±11%;P<0.001)和脂肪变性(17±7%与 2±3%;P<0.001)在体重减轻后显著降低。CYP3A4/5 蛋白含量无变化(57±13%与 55±13%;P=0.433)。减肥手术后,脂质过氧化的减少与 CYP2E1 蛋白表达的变化独立相关(r=0.477;P=0.033)。

结论

NAFLD 中升高的肝脂质过氧化和 CYP2E1 表达在减肥手术后通过减肥手术引起的体重减轻显著改善。

相似文献

1
Bariatric surgery-induced weight loss reduces hepatic lipid peroxidation levels and affects hepatic cytochrome P-450 protein content.减重手术引起的体重减轻可降低肝脂质过氧化水平,并影响肝细胞色素 P-450 蛋白含量。
Ann Surg. 2010 Jun;251(6):1041-8. doi: 10.1097/SLA.0b013e3181dbb572.
2
Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.儿童非酒精性脂肪性肝病及其亚型中的肝脂质过氧化和细胞色素 P-450 2E1。
J Clin Gastroenterol. 2011 Oct;45(9):800-7. doi: 10.1097/MCG.0b013e31821377e4.
3
CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis.细胞色素P450 2E1增强暴饮酒精诱导的肠道通透性增加、脂肪性肝炎和细胞凋亡。
Free Radic Biol Med. 2013 Dec;65:1238-1245. doi: 10.1016/j.freeradbiomed.2013.09.009. Epub 2013 Sep 21.
4
CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis.细胞色素P450 2E1和细胞色素P450 4A作为小鼠非酒精性脂肪性肝炎中脂质过氧化物的微粒体催化剂。
J Clin Invest. 2000 Apr;105(8):1067-75. doi: 10.1172/JCI8814.
5
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝脏中的细胞色素P450 2E1水平升高。
Hepatology. 1998 Jan;27(1):128-33. doi: 10.1002/hep.510270121.
6
CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.患有非酒精性脂肪性肝病的病态肥胖受试者体重减轻前后的CYP2E1活性
Hepatology. 2003 Aug;38(2):428-35. doi: 10.1053/jhep.2003.50342.
7
Hepatic cytochrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease.非酒精性脂肪性肝病进展阶段人类肝微粒体细胞色素 P450 酶的改变。
Drug Metab Dispos. 2009 Oct;37(10):2087-94. doi: 10.1124/dmd.109.027466. Epub 2009 Aug 3.
8
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.抑制甘油三酯合成可改善非酒精性脂肪性肝炎肥胖小鼠的肝脂肪变性,但会加重肝损伤和肝纤维化。
Hepatology. 2007 Jun;45(6):1366-74. doi: 10.1002/hep.21655.
9
Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中肝脏细胞色素P450 2E1活性
J Med Assoc Thai. 2008 May;91(5):733-8.
10
Increased expression of cytochrome P450 2E1 in nonalcoholic fatty liver disease: mechanisms and pathophysiological role.非酒精性脂肪性肝病中细胞色素 P450 2E1 的表达增加:机制和病理生理作用。
Clin Res Hepatol Gastroenterol. 2011 Oct;35(10):630-7. doi: 10.1016/j.clinre.2011.04.015. Epub 2011 Jun 12.

引用本文的文献

1
Impact of bariatric surgery on cytochrome P 450 enzyme activity.减肥手术对细胞色素P450酶活性的影响。
Front Pharmacol. 2024 Mar 25;15:1372950. doi: 10.3389/fphar.2024.1372950. eCollection 2024.
2
Opioid Analgesics after Bariatric Surgery: A Scoping Review to Evaluate Physiological Risk Factors for Opioid-Related Harm.减重手术后的阿片类镇痛药:一项评估阿片类药物相关危害生理风险因素的范围综述
J Clin Med. 2023 Jun 27;12(13):4296. doi: 10.3390/jcm12134296.
3
Mechanisms linking bariatric surgery to adipose tissue, glucose metabolism, fatty liver disease and gut microbiota.

本文引用的文献

1
Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.细胞色素P450 2E1在非酒精性脂肪变性和脂肪性肝炎患者中的表达及活性
Liver Int. 2007 Aug;27(6):764-71. doi: 10.1111/j.1478-3231.2007.01524.x.
2
Association between nonalcoholic hepatic steatosis and hepatic cytochrome P-450 3A activity.非酒精性肝脂肪变性与肝细胞色素P-450 3A活性之间的关联。
Clin Gastroenterol Hepatol. 2007 Mar;5(3):388-93. doi: 10.1016/j.cgh.2006.12.021.
3
Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome.
肥胖症手术与脂肪组织、葡萄糖代谢、脂肪肝疾病和肠道微生物组的关联机制。
Langenbecks Arch Surg. 2023 Feb 24;408(1):101. doi: 10.1007/s00423-023-02821-8.
4
Sleeve Gastrectomy Ameliorates Diabetes-Related Spleen Damage by Improving Oxidative Stress Status in Diabetic Obese Rats.袖状胃切除术通过改善糖尿病肥胖大鼠的氧化应激状态来改善糖尿病相关的脾脏损伤。
Obes Surg. 2021 Mar;31(3):1183-1195. doi: 10.1007/s11695-020-05073-3. Epub 2020 Oct 26.
5
Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes.非酒精性脂肪性肝病(NAFLD)与肝脏细胞色素P450(CYP)酶
Pharmaceuticals (Basel). 2020 Aug 29;13(9):222. doi: 10.3390/ph13090222.
6
Serum Malondialdehyde is Associated with Non-Alcoholic Fatty Liver and Related Liver Damage Differentially in Men and Women.血清丙二醛与非酒精性脂肪肝及相关肝损伤在男性和女性中的关联存在差异。
Antioxidants (Basel). 2020 Jul 2;9(7):578. doi: 10.3390/antiox9070578.
7
Untargeted Metabolomic Analysis of the Effects and Mechanism of Nuciferine Treatment on Rats With Nonalcoholic Fatty Liver Disease.荷叶碱治疗非酒精性脂肪性肝病大鼠的作用及机制的非靶向代谢组学分析
Front Pharmacol. 2020 Jun 9;11:858. doi: 10.3389/fphar.2020.00858. eCollection 2020.
8
Role of cytoglobin, a novel radical scavenger, in stellate cell activation and hepatic fibrosis.新型自由基清除剂细胞红蛋白在星状细胞活化及肝纤维化中的作用
Clin Mol Hepatol. 2020 Jul;26(3):280-293. doi: 10.3350/cmh.2020.0037. Epub 2020 Jun 4.
9
Apoptotic effects of hsian-tsao ( Hemsley) on hepatic stellate cells mediated by reactive oxygen species and ERK, JNK, and caspase-3 pathways.仙草(Hemsley)通过活性氧以及ERK、JNK和半胱天冬酶-3信号通路介导对肝星状细胞的凋亡作用。
Food Sci Nutr. 2019 Apr 22;7(5):1891-1898. doi: 10.1002/fsn3.1046. eCollection 2019 May.
10
Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders.关注精神疾病神经代谢病理生理学中的脂肪酸。
J Inherit Metab Dis. 2018 Jul;41(4):597-611. doi: 10.1007/s10545-018-0158-3. Epub 2018 Mar 9.
手术诱导的体重减轻显著改善非酒精性脂肪性肝病和代谢综合征。
Ann Surg. 2005 Oct;242(4):610-7; discussion 618-20. doi: 10.1097/01.sla.0000179652.07502.3f.
4
Activity of CYP2E1 and CYP3A enzymes in adults with moderate alcohol consumption: a comparison with nonalcoholics.中度饮酒成年人中CYP2E1和CYP3A酶的活性:与不饮酒者的比较。
Hepatology. 2005 May;41(5):1144-50. doi: 10.1002/hep.20673.
5
Effect of body mass index on nonalcoholic fatty liver disease in patients undergoing minimally invasive bariatric surgery.体重指数对接受微创减肥手术患者非酒精性脂肪性肝病的影响。
J Gastrointest Surg. 2004 Nov;8(7):849-55. doi: 10.1016/j.gassur.2004.07.001.
6
Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者体内脂质过氧化的全身水平及其代谢和饮食相关性。
Am J Gastroenterol. 2004 Aug;99(8):1497-502. doi: 10.1111/j.1572-0241.2004.30159.x.
7
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.非酒精性脂肪性肝病:体重减轻可改善肝脏组织学分析结果
Hepatology. 2004 Jun;39(6):1647-54. doi: 10.1002/hep.20251.
8
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis.
Surgery. 2004 Jan;135(1):48-58. doi: 10.1016/j.surg.2003.10.003.
9
CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease.患有非酒精性脂肪性肝病的病态肥胖受试者体重减轻前后的CYP2E1活性
Hepatology. 2003 Aug;38(2):428-35. doi: 10.1053/jhep.2003.50342.
10
Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎非糖尿病患者的肝细胞色素P450 2E1活性
Hepatology. 2003 Mar;37(3):544-50. doi: 10.1053/jhep.2003.50095.